Paid Clinical Trials in Hartford, CT
As of June 2026, 252 paid clinical trials are recruiting in Hartford, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hartford offers studies at sites including Hartford Hospital for conditions such as Neuroblastoma, Degenerative Disc Disease, Stage IV Lung Cancer AJCC v8, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hartford
Trials by drug in Hartford
Filter results
252 clinical trials
↓ Download CSVA Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Psilocybin Microdosing on Cognition, Mood and Quality of Life
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Interoceptive Awareness and Function in Adolescents With Chronic Pain
A Study of Brenipatide in Adult Participants With Schizophrenia
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs
Digoxin Medulloblastoma Study
Assessing Post-operative Outcomes After Children's Sistrunk Procedure With or Without a Drain
Lead Evaluation for Defibrillation and Reliability Post Approval Study
Opt-In Early Pilot Study
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
I-DECIDE After Bronchiolitis Hospitalization
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Pilot Trial of Mobile Technology for Adolescent Suicidality
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
ELEVATE-HFpEF Clinical Study
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Pilot fMRI Studies of Aging-Related Effects of THC
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
About research studies in Hartford
Hartford has approximately 252 recruiting research studies across a wide range of therapeutic areas. Connecticut hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Hartford
Researchers run research studies in Hartford, CT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hartford Hospital | Coronary Artery Disease, Heart Failure, Anatomic Stage II Breast Cancer AJCC v8 | 63 |
| Connecticut Children's Medical Center | Sickle Cell Disease, B Acute Lymphoblastic Leukemia, Crohn's Disease | 61 |
| Smilow Cancer Hospital Care Center at Saint Francis | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 39 |
| Hartford Healthcare | Advanced Solid Tumor, Alcohol Use Disorder, Bipolar 1 Disorder | 15 |
| Connecticut Children's Hospital | Neuroblastoma, Atypical Teratoid/Rhabdoid Tumor, DIPG Brain Tumor | 8 |
| Connecticut Children's | Glycogen Storage Disease Type I, Glycogen Storage Disease Type IA, Glycogen Storage Disease Type IB | 5 |
| Hartford Healthcare Alliance (Data Collection Only) | Advanced Melanoma, Gastrointestinal Cancer, Glioma | 3 |
| Hartford Healthcare Bone and Joint Institute | Degenerative Disc Disease, Cervical Spinal Instability, Degenerative Scoliosis | 3 |
| Hartford Healthcare Cancer Institute @ Hartford Hospital | Acute Leukemia, Endometrial Cancer, Endometrial Cancer Stage I | 3 |
| Smilow Cancer Hospital at Saint Francis | Breast Cancer, HER2-positive Metastatic Breast Cancer, Metastatic Breast Cancer | 3 |
| Hartford Healthcare Cancer Institute at Hartford Hospital | Cervical Cancer, Hepatocellular Carcinoma | 2 |
| Institute of Living | Major Depressive Disorder, Schizophrenia | 2 |
| Olin Neuropsychiatry Research Center | Opioid Overdose, Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI | 2 |
| St. Francis Hospital and Medical Center | Adenocarcinoma, Pancreatic Ductal, Open Midline Laparotomy | 2 |
| Connecticut Children's Medical Center - Hartford | Duchenne Muscular Dystrophy, Crohn's Disease | 2 |
| Hartford HealthCare Cancer Institute | Acute Myeloid Leukemia (AML), Chemotherapy-induced Peripheral Neuropathy, Gynecologic Cancer | 2 |
| Alkermes Investigator Site | Bipolar I Disorder, Schizophrenia | 1 |
| Anxiety Disorders Center, Institute of Living | Hoarding Disorder | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Hypophosphatasia | 1 |
| Connecticut Army National Guard | Suicide | 1 |
| Connecticut Children's Medical Center, Neurology Division | Duchenne Muscular Dystrophy | 1 |
| Hartford Health Care | Atrial Fibrillation (AF), VTE | 1 |
| Hartford Health Hospital | Stroke, Stroke, Acute, Stroke, Ischemic | 1 |
| Hartford HealthCare - Hartford Hospital | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | 1 |
Active & Upcoming Studies in Hartford (2026)
Recruiting trials in Hartford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (97 active studies)
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · Phase 1, Phase 2 · Milton S. Hershey Medical Center
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Cardiovascular (19 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · University of Connecticut
Neurology & pain (13 active studies)
- Interoceptive Awareness and Function in Adolescents With Chronic Pain · Connecticut Children's Medical Center
- MMA Embolization for Refractory Chronic Migraine · Cerenovus, Part of DePuy Synthes Products, Inc.
Pediatric (8 active studies)
- Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease · Connecticut Children's Medical Center
- Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs · Kimberley Roche
Mental health & behavior (6 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs · Kimberley Roche
Diabetes & metabolic (6 active studies)
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · University of Connecticut
- Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy · Hartford HealthCare
Vaccines (1 active study)
Common conditions studied in Hartford
- Neuroblastoma (9 active studies). Recruiting Neuroblastoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Degenerative Disc Disease (7 active studies). Recruiting Degenerative Disc Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IV Lung Cancer AJCC v8 (6 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Breast Cancer (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Heart Failure (5 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Hartford
- National Cancer Institute (NCI)
- Children's Oncology Group
- Connecticut Children's Medical Center
- SWOG Cancer Research Network
- Hartford Hospital
Local regulations and guidelines
Clinical trials in Connecticut are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Connecticut research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Hartford. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Hartford
Hipa.ai aggregates every recruiting study in Hartford from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Hartford?
There are approximately 252 recruiting clinical trials in Hartford, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hartford pay participants?
Most recruiting trials in Hartford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hartford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hartford?
The most common conditions under active study in Hartford include Neuroblastoma (9), Degenerative Disc Disease (7), Stage IV Lung Cancer AJCC v8 (6), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hartford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hartford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hartford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hartford?
Recruiting research sites in Hartford include Hartford Hospital, Connecticut Children's Medical Center, Smilow Cancer Hospital Care Center at Saint Francis, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hartford right now?
The largest active categories in Hartford are Cancer & tumors (97), Cardiovascular (19), Neurology & pain (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.